Syntara the science explained, page-9

Hi Melbstorm,

You certainly are star gazing the science. I like that.

Try this list for off label medication for SNT-5505.

Fibrotic diseases and certain cancers with connective tissue components.

Kidney fibrosis

Lung fibrosis

Pancreatic cancer

Liver cancer

https://www.pharmaxis.com.au/product-pipeline/amine-oxidase-platform/oral-pan-lox-inhibitor/

By inhibiting all lysl oxidase isoform, pan-lox inhibitors could potentially limit fibrosis and "tumor stroma" ( imagine the building protecting the cancer site)

https://pubmed.ncbi.nlm.nih.gov/26848785/

Kpax